Navigation Links
PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
Date:7/24/2009

results or effectiveness and/or may not generate data that would support the approval or marketing of these products for the indications being studied or for other indications; that ongoing studies may not continue to show substantial or any activity; that the actual dollar amount of any grants from the OCS is uncertain and is subject to policy changes of the Israeli government, and that such grants may be insufficient to assist with product development; and other risks and uncertainties that may cause results to differ materially from those set forth in the forward-looking statements. The development of any products using the CTP platform technology could also be affected by a number of other factors, including unexpected safety, efficacy or manufacturing issues, additional time requirements for data analyses and decision making, the impact of pharmaceutical industry regulation, the impact of competitive products and pricing and the impact of patents and other proprietary rights held by competitors and other third parties. In addition to the risk factors set forth above, investors should consider the economic, competitive, governmental, technological and other factors discussed in PROLOR's filings with the Securities and Exchange Commission. 

    PROLOR CONTACT:                     MEDIA CONTACT:
    Shai Novik, President               Barbara Lindheim
    PROLOR Biotech, Inc.                GendeLLindheim BioCom Partners
    Tel: +1 866 644-7811                +1 212 918-4650
    Email: shai@prolor-biotech.com


'/>"/>
SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
3. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
4. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
5. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
6. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
7. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
8. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
9. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
10. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
11. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...s have an opportunity to take the lead in two smal...ersity of Valencia (UV), working together with the...abric of the Spanish biotechnology industry. Their... have more clout than those in English-speaking co...plants has been overlooked by the leading countrie...
(Date:11/20/2009)...Newswire-FirstCall/ -- Cell Therapeutics, Inc. (CT... Ninth Circuit Court of Appeals reversed a U.S. Di...lowed to pursue all of its claims against The Lash...t for trial. CTI filed a complaint against The La...onsultant for CTI,s product TRISENOX, in 2007 seek...
(Date:11/19/2009)...wire-FirstCall/ -- Omeros Corporation (Nasdaq: OM...or the third quarter ended September 30, 2009. For... reported a net loss of $3.9 million, or $1.34 per... or $2.54 per share, for the same period in 2008. ...Company reported a net loss of $15.5 million, or $...
(Date:11/19/2009)...THAM, Mass., Nov. 19 Arlington Med...hat the leading driver of antibiotic selection in ...ctivity against gram-positive and gram-negative pa...cause nosocomial pneumonia, surveyed European phys...that provide appropriate coverage against common p...
Breaking Biology Technology:Spanish biotechnology should focus on food and plant sectors to be more competitive 2Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
.../ -- Biostar Pharmaceuticals,Inc. ("Biostar" or th...rted,financial results for the three months ended ... of $7,447,664 for the quarter ended March 31,2009...r of 2008. Net Income,for the first quarter 2009 w...ed basis, versus $1,821,130, or $0.08 per share, r...
...e II Study Evaluating Bavituximab in Advanced Brea...Data from Phase I Study Evaluating Bavituximab in ... Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM)...oping monoclonal antibodies for the treatment of c... that data from two ongoing clinical trials assess...
...y and Manage Quality at New LIFE Nutrition Factory...eywell (NYSE: HON ) today announced that it has ...cturer of healthcare products, to provide process ...uce clinical nutrition and infusion therapy soluti...trition plant, now under construction in Melsungen...
Other Biology Technology:Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 2Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 3Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 4Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 5Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009 6Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting 2Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting 3Clinical Data on Peregrine's Bavituximab Cancer Program to Be Discussed in Two Presentations at 2009 ASCO Annual Meeting 4Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 2Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 3Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 4
(Date:11/20/2009)...gy Research Center (ERC) has been awarded a grant ...p methods of recovering and reusing the heat that ...ompression process in a carbon capture system. The...bon capture and sequestration, or storage (CCS), a...s, emitted into the atmosphere by coal-fired power...
(Date:11/19/2009)...ng brain chemical with an unwieldy name: 4-hydroxy...or used as a date-rape drug. , Now, a team of O...utes by which 4-HB is metabolized by the body. "Th...ael Gibson, professor and chair of biological scie...mber of the research team. "It may provide new cl...
(Date:11/19/2009)...s, which cultivate fungus for food, have many rema...the list: the ant farmers, like their human counte... their gardens grow. The finding, reported this we... previously unknown symbiosis between ants and bac...ts have come to dominate the American tropics and ...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Researchers begin to decipher metabolism of sexual assault drug 2Like humans, ants use bacteria to make their gardens grow 2No Votes on Health Care Bill Received 242 3 Million More from Health Insurance Industry 60990 1No Votes on Health Care Bill Received 242 3 Million More from Health Insurance Industry 60990 2PETCO Stores Nationwide Host Pet Nutrition Workshops 60988 1Haft Group says Bullish Commodity Market Triggers Small and Micro cap Upsurge 14769 1Haft Group says Bullish Commodity Market Triggers Small and Micro cap Upsurge 14769 2
... unusual intersection of materials science and ant... of Standards and Technology (NIST) and The George...s-science-based mathematical models to help shed l...historic relatives. Their work forms part of a new...arly hominid Australopithecus africanus by anthrop...
...entity and origin of tiny, potentially hazardous p...een revealed by a new study at Queensland Universi...m QUT,s International Laboratory for Air Quality a...d by earlier findings that almost one third of pop...fine particles. , These tiny particles are potent...
...X, Ariz. Feb. 11, 2009 The Van Andel Research In...arch Institute (TGen) will forge a strategic allia...ide contributions to science and health. , The no...oday the initiation of an "alliance and affiliatio...pids, Mich.-based VARI and Phoenix, Ariz.-based TG...
Other Biology News:Toothsome research: Deducing the diet of a prehistoric hominid 2Van Andel Research Institute and TGen undertake alliance to promote science and health 2Van Andel Research Institute and TGen undertake alliance to promote science and health 3
...virus (CMV) pp65 Antigenemia Immunofluorescence As...cation of lower matrix protein pp65 of CMV in isol... Erythrocyte Lysis Buffer - (Catalog No. 5122)... chloride. (NH4CL) Fixation Solution (5X) - (Cata...
CultureWell multislip cell culture system MSI-12 *plate and insert fifteen 12 mm coverslips per insert* *set of 10* from Molecular Probes (Invitrogen)
Rabbit Anti-Human NCBP1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Goat Anti-Human SLI Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: